Animal Health Active Pharmaceutical Ingredients Market Key Highlights:
- Market Size (2024): USD 64.97 Billion
- Projected Market Size (2034): USD 116.39 Billion
- CAGR (2023-2034): 5.3%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Animal Health Active Pharmaceutical Ingredients Market Definition
The animal health active pharmaceutical ingredients market deals with substances to enhance or maintain animal health. This includes APIs for veterinary medicine segments such as vaccines, anti-infectives and anti-parasitics, essential for promoting growth and productivity and treating diseases. The necessity for these APIs increases from the rising demand for the consequential growth in livestock production and protein-rich diets globally. The market growth is driven by increasing number of animal healthcare NGOs and growing focus on animal wellbeing.
In addition, leading to the abundance of pharmaceutical companies in the various regions, there has been a major growth of the antiparasitic API landscape. In these regions, major market players are collaborating to form joint ventures and alliances to gain an edge in market competition. In addition, the increasing unmet medical needs act as a major factor driving the growth of the animal health active pharmaceutical ingredients market.
Animal Health Active Pharmaceutical Ingredients Market Segmentation:
By Type
- Antiparasitics
- Anti-infectives
- NSAIDs & Anesthetics
- Others
By Application
- Pharmacy
- Pet Hospital
- Other
Animal Health Active Pharmaceutical Ingredients Market Companies:
- Glenmark Pharmaceutical
- Zoetis
- Eli Lilly
- Sanofi Winthrop Industrie
- Indukern
- P&R SpA (Olon SpA)
- Lonza Group
- Huvepharma
- Sequent Scientific
- NGL Fine Chem.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
